Related Experiment Videos

In vivo reduction of arsenate in mice and rabbits

Environmental Research
|October 1, 1983
PubMed

Insights

In vivo studies show that arsenate (AsV) must be reduced to arsenite (AsIII) before methylation occurs. This reduction and subsequent metabolism of arsenic were observed in mice and rabbits.

Area of Science:

  • Biochemistry
  • Toxicology
  • Pharmacokinetics

Background:

  • Arsenic (As) is a metalloid with various oxidation states, including arsenate (AsV) and arsenite (AsIII).
  • Understanding arsenic metabolism in vivo is crucial for assessing its toxicity and developing effective treatments.

Purpose of the Study:

  • To investigate the in vivo reduction of arsenate (AsV) to arsenite (AsIII) in mammalian models.
  • To determine the metabolic pathway of arsenic, specifically the order of reduction and methylation.

Main Methods:

  • Administration of radiolabeled [74As]arsenate to mice and rabbits.
  • Quantification of arsenic metabolites (AsV, AsIII, dimethylarsinic acid) in plasma and urine samples.
  • Continuous urine collection in catheterized rabbits to track excretion patterns.

Main Results:

  • Arsenite (AsIII) was detected in mouse plasma and urine within 1 hour post-administration, indicating rapid reduction of arsenate (AsV).
  • In rabbits, approximately 10% of the administered arsenate was reduced and excreted as AsIII within 4 hours.
  • Excretion patterns showed initial AsV and AsIII, followed by increased excretion of AsIII and dimethylarsinic acid, suggesting a sequential metabolic process.

Conclusions:

  • The in vivo reduction of arsenate (AsV) to arsenite (AsIII) is a necessary prerequisite for arsenic methylation.
  • These findings elucidate a critical step in the toxicokinetics and metabolic pathway of arsenic in mammals.

Related Concept Videos